Newsroom
Articles
Glossary
Trendletter
Home
Subscribe to the Trendletter
E-mail 
Search 

Bookmark and Share


      About Us            Services            Clients            Contact Us            òáøéú      
Signal Business Development leads its clients’ international business development efforts with industry-focused knowledge, experience and contacts, to achieve deal-oriented success.
 
We focus on medtech, healthcare, biotech, agritech, cleantech, IT, mobile and Internet, security, plastics and chemicals, and consumer products. Signal Business Development is a member of The Trendlines Group.



Business Development
Profiling, identifying, qualifying, contacting, negotiating with strategic partners
Channel Development
Building sales infrastructures, trade show assistance, representation

Business Growth
Analyzing opportunities and developing actionable marketing/business plans.
Marketing Communications
Developing effective materials that deliver powerful messages


4 steps to "channeling" your business
What stands between you and getting more orders? This question is being asked everywhere today as sales and marketing departments look over their monthly sales reports. The answer is simple: Your sales channels, of course.

A Regulatory Primer
This series from Roger Gray of Donawa Consulting focuses on critical regulatory hurdles that must be overcome before medical device products can be sold in the major world markets.

The business plan process
A Signal business plan is the written reflection of our interpretations from our clients and from our research.

Tips for meaningful meetings
How to turn an "okay" meeting into a "meaningful" event.

Starting off right with a website
A website presents the ‘online face’ of your company, and is a must-have for any company, even one in the early stages of its business life.

11 tips for successful PR
In these dramatic times, visibility through PR is absolutely imperative for your company. Linda Kedem of Rainier PR gives 11 tips how PR can keep the market informed about your company's activities.


Kamada begins inhalable AAT trial
Mira Awwad Globes[Online] 26 January 2010

Kamada wins Brazilian orders
Hillel Koren, Globes [online], January 10, 2010

OTI share doubles on $30m US electronic ID contracts
Globes' correspondent, 5 January 2010

Wound care co EnzySurge raises $4.1m
Gali Weinreb, Globes [online], January 5, 2010


  Directions     Privacy Policy     Site Map     Tel: +972.72.260.7000
©2010 The Trendlines Group Ltd. All rights reserved. This site contains material copyrighted by third parties.